echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > [Heavyweight] Yuandong’s first oral hypoglycemic drug will be approved, targeting Hausen’s star products

    [Heavyweight] Yuandong’s first oral hypoglycemic drug will be approved, targeting Hausen’s star products

    • Last Update: 2021-11-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Wonderful content



    Figure 1: Yuandong's registration progress of repaglinide and metformin tablets

    Source: NMPA official website


    Repaglinide Metformin Tablets is a compound hypoglycemic drug that combines two different mechanisms of action to improve the blood sugar control of patients with type 2 diabetes.



    Figure 2: The medical insurance status of Repaglinide Metformin Tablets

    Source: Meinenet China Medical Insurance Catalog Encyclopedia Database


    Jiangsu Haosen Pharmaceutical Co.



    According to data from Meinnet.



    Source: Mi Nei.


    The review data statistics are as of October 27, if there are any errors or omissions, please correct me



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.